BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9865917)

  • 1. Gamma-ray mutagen sensitivity and survival in patients with glioma.
    Sigurdson AJ; Bondy ML; Hess KR; Toms SA; Kyritsis AP; Gu J; Wang LE; Wang X; Adatto P; Bruner JL; Yung WK; Levin VA; Wei Q
    Clin Cancer Res; 1998 Dec; 4(12):3031-5. PubMed ID: 9865917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagen sensitivity and risk of gliomas: a case-control analysis.
    Bondy ML; Kyritsis AP; Gu J; de Andrade M; Cunningham J; Levin VA; Bruner JM; Wei Q
    Cancer Res; 1996 Apr; 56(7):1484-6. PubMed ID: 8603389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of the immunohistochemical staining of cleaved caspase-3, an activated form of caspase-3, in gliomas.
    Kobayashi T; Masumoto J; Tada T; Nomiyama T; Hongo K; Nakayama J
    Clin Cancer Res; 2007 Jul; 13(13):3868-74. PubMed ID: 17606719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
    Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-radiation sensitivity and risk of glioma.
    Bondy ML; Wang LE; El-Zein R; de Andrade M; Selvan MS; Bruner JM; Levin VA; Alfred Yung WK; Adatto P; Wei Q
    J Natl Cancer Inst; 2001 Oct; 93(20):1553-7. PubMed ID: 11604478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy.
    Chang JY; Komaki R; Sasaki R; Liao Z; Stevens CW; Lu C; Fossella FV; Allen PK; Cox JD; Spitz MR; Wu X
    Clin Cancer Res; 2005 Apr; 11(8):2894-8. PubMed ID: 15837739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma radiation sensitivity and risk of malignant and benign salivary gland tumors: a pilot case-control analysis.
    Zheng R; Wang LE; Bondy ML; Wei Q; Sturgis EM
    Cancer; 2004 Feb; 100(3):561-7. PubMed ID: 14745873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multivariate analysis of the prognostic factors of grade III gliomas.
    Zhu YJ; Zhu XD; Wang SH; Shen F; Shen H; Liu WG
    Chin Med J (Engl); 2008 Jun; 121(12):1072-5. PubMed ID: 18706219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.
    Li X; Jin H; Lu Y; Oh J; Chang S; Nelson SJ
    NMR Biomed; 2004 Feb; 17(1):10-20. PubMed ID: 15011246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma.
    Alexander A; Murtha A; Abdulkarim B; Mehta V; Wheatley M; Murray B; Riauka T; Hanson J; Fulton D; McEwan A; Roa W
    Clin Invest Med; 2006 Oct; 29(5):301-11. PubMed ID: 17144440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.
    Gravendeel LA; Kouwenhoven MC; Gevaert O; de Rooi JJ; Stubbs AP; Duijm JE; Daemen A; Bleeker FE; Bralten LB; Kloosterhof NK; De Moor B; Eilers PH; van der Spek PJ; Kros JM; Sillevis Smitt PA; van den Bent MJ; French PJ
    Cancer Res; 2009 Dec; 69(23):9065-72. PubMed ID: 19920198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.
    Wang LE; Xiong P; Strom SS; Goldberg LH; Lee JE; Ross MI; Mansfield PF; Gershenwald JE; Prieto VG; Cormier JN; Duvic M; Clayman GL; Weber RS; Lippman SM; Amos CI; Spitz MR; Wei Q
    J Natl Cancer Inst; 2005 Dec; 97(24):1822-31. PubMed ID: 16368944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near complete surgical resection predicts a favorable outcome in pediatric patients with nonbrainstem, malignant gliomas: results from a single center in the magnetic resonance imaging era.
    Bucci MK; Maity A; Janss AJ; Belasco JB; Fisher MJ; Tochner ZA; Rorke L; Sutton LN; Phillips PC; Shu HK
    Cancer; 2004 Aug; 101(4):817-24. PubMed ID: 15305415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
    Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
    J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioma vascularity correlates with reduced patient survival and increased malignancy.
    Russell SM; Elliott R; Forshaw D; Golfinos JG; Nelson PK; Kelly PJ
    Surg Neurol; 2009 Sep; 72(3):242-6; discussion 246-7. PubMed ID: 19329156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy in supratentorial gliomas. A study of 821 cases.
    Heesters M; Molenaar W; Go GK
    Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
    Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
    Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic factors for deep situated malignant gliomas treated with linac radiosurgery].
    Wang YY; Bao XF; Li SY; Wu CY
    Ai Zheng; 2002 Oct; 21(10):1149-53. PubMed ID: 12508664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of re-irradiation in malignant glioma: a single-center experience.
    Bartsch R; Weitmann HD; Pennwieser W; Wenzel C; Muschitz S; Baldass M; Hassler M; Marosi C; Rössler K; Pötter R; Dieckmann K
    Wien Klin Wochenschr; 2005 Dec; 117(23-24):821-6. PubMed ID: 16437319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a canadian cancer center.
    Gill S; Shah A; Le N; Cook EF; Yoshida EM
    J Clin Oncol; 2003 Jun; 21(11):2070-6. PubMed ID: 12775731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.